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We conducted a feasibility study to predict malignant glioma grades via radiomic analysis using 
contrast-enhanced T1-weighted magnetic resonance images (CE-T1WIs) and T2-weighted magnetic 
resonance images (T2WIs). We proposed a framework and applied it to CE-T1WIs and T2WIs (with tumor 
region data) acquired preoperatively from 157 patients with malignant glioma (grade III: 55, grade IV: 
102) as the primary dataset and 67 patients with malignant glioma (grade III: 22, grade IV: 45) as the 
validation dataset. Radiomic features such as size/shape, intensity, histogram, and texture features 
were extracted from the tumor regions on the CE-T1WIs and T2WIs. The Wilcoxon–Mann–Whitney 
(WMW) test and least absolute shrinkage and selection operator logistic regression (LASSO-LR) were 
employed to select the radiomic features. Various machine learning (ML) algorithms were used to 
construct prediction models for the malignant glioma grades using the selected radiomic features. 
Leave-one-out cross-validation (LOOCV) was implemented to evaluate the performance of the 
prediction models in the primary dataset. The selected radiomic features for all folds in the LOOCV of 
the primary dataset were used to perform an independent validation. As evaluation indices, accuracies, 
sensitivities, specificities, and values for the area under receiver operating characteristic curve (or 
simply the area under the curve (AUC)) for all prediction models were calculated. The mean AUC value 
for all prediction models constructed by the ML algorithms in the LOOCV of the primary dataset was 
0.902 ± 0.024 (95% CI (confidence interval), 0.873–0.932). In the independent validation, the mean 
AUC value for all prediction models was 0.747 ± 0.034 (95% CI, 0.705–0.790). The results of this study 
suggest that the malignant glioma grades could be sufficiently and easily predicted by preparing the CE-
T1WIs, T2WIs, and tumor delineations for each patient. Our proposed framework may be an effective 
tool for preoperatively grading malignant gliomas.
Gliomas are primary brain tumors caused by glial cell mutations. The latest reports from the brain tumor registry 
of Japan indicate that 27% of brain tumor patients in Japan suffered from gliomas between 2005–20081. Gliomas 
are classified into four grades in accordance with the pathology and genotypic figures issued by the World Health 
Organization (WHO)2. A surgical approach of removing the visible tumor tissue is typically applied to all glioma 
grades after imaging diagnosis based on computed tomography (CT), magnetic resonance (MR), and positron 
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emission tomography (PET) images. Adjuvant therapy (namely chemotherapy, radiotherapy, or chemoradio-
therapy) after surgery is used to treat high-grade gliomas (HGGs) to address the inevitable extension of tumors 
beyond margins suggested by imaging3. The glioma grade is determined based on pathological and genetic fea-
tures of the tissues. Although an imaging diagnosis is preoperatively performed to approximate the malignancy 
of the tumor, the grade is usually determined based on the tissue obtained from a biopsy or resection during 
surgery. Glioma grading using medical imaging should be performed prior to surgery for increasing treatment 
effects while decreasing adverse events. In addition, predicting glioma grades using preoperative images is useful 
for patient education before surgery.
Methodologies for predicting glioma grades using MR or CT images have been described in previous stud-
ies4–11. One concept for predicting the glioma grade is to construct statistical models using some tumor appear-
ance features or imaging indices. A more comprehensive analysis using more quantitative imaging features may 
provide better accuracy in predicting glioma grades. For this reason, we investigated the feasibility of radiomics 
in predicting glioma grades.
Radiomics is a comprehensive analysis for describing tumor phenotypes based on high-dimensional quan-
titative features extracted from the large quantity of medical images collected12–14. It has the potential to be an 
effective tool for personalized medicine based on phenotypic descriptions of tumors from medical images12, 
allowing for noninvasive analysis of tumor characteristics comparable with molecular biological approaches such 
as genomics, epigenomics, transcriptomics, and proteomics12. Some studies for predicting glioma grades based 
on radiomics using MR images have been conducted15–22. Qin et al., Cho et al., Chen et al., and Vamvakas et 
al. proposed frameworks for classifying low-grade gliomas (LGGs) and HGGs using images acquired by mul-
tiple MR imaging (MRI) sequences15–19. Predicting LGGs and HGGs could be made possible by constructing 
radiomics-based classifiers using machine learning (ML) algorithms in those frameworks. Zacharaki et al. and 
Tian et al. investigated the prediction of grade III and IV gliomas as well as the classification of LGGs and HGGs 
using images acquired via multiple MRI sequences20,21. Zhang et al. investigated both the classification of LGGs 
and HGGs and the prediction of grade II, III, and IV gliomas22. However, in previous studies, all of which used 
multiple MRI sequences, tumors needed to be contoured on each MR image for radiomic analysis of each patient, 
indicating that radiomic analysis for grading gliomas could not be performed unless all images acquired by the 
multiple MRI sequences were prepared in this manner. Considerable time and effort would be required to pre-
pare tumor contours on multiple MRI sequences images for all the patients in the database. In addition, if the 
images acquired by a special MRI sequence were used for a framework for glioma grading based on radiomics, 
the framework would not have versatility for use in other institutions. Therefore, predicting the glioma grade 
before surgery in a straightforward manner using a few structural MRI sequences images usually acquired by the 
majority of institutions and volumes of interest of the tumor regions in each patient is crucial. Reza et al. verified 
the effect of three structural MRI sequences images (contrast-enhanced T1-weighted MR images (CE-T1WIs), 
T2-weighted MR images (T2WIs), and fluid attenuated inversion recovery (FLAIR) images) for classifying the 
LGGs and HGGs, and LGGs and grade IV gliomas using a few datasets23. However, there would be no radiomic 
study for verifying the effect of a few structural MRI sequences images for predicting malignant glioma grades 
(namely grades III and IV) using various ML algorithms.
Therefore, the purpose of this study was to investigate the feasibility of predicting malignant glioma grades 
based on radiomic analysis using the CE-T1WIs and T2WIs acquired before surgery.
Materials and Methods
Overall study design. Figure 1 shows a conceptual design for predicting glioma grades based on radiomic 
features. The database in this study consisted of primary dataset collected in public database and validation data-
set collected in our hospital. The high-dimensional radiomic features were extracted from tumor regions on 
the CE-T1WIs and T2WIs for all patients in the primary and validation datasets. A Wilcoxon–Mann–Whitney 
(WMW) test and least absolute shrinkage and selection operator logistic regression (LASSO-LR) were employed 
for selecting the extracted radiomic features to construct prediction models using features potentially related 
to glioma grades. The prediction models were constructed using the LR, a support vector machine (SVM), a 
standard neural network (SNN), a random forest (RF), and a naïve Bayes (NB). A leave-one-out cross-valida-
tion (LOOCV) was undertaken for evaluating the performance of the prediction models in the primary dataset. 
Finally, an independent validation was performed using the primary and validation datasets with selected radi-
omic features for all folds in the LOOCV of the primary dataset.
Database and equipment. This study was performed in accordance with relevant guidelines and regula-
tions approved by the institutional review board at the University of Tokyo hospital. Ethical approval for the study 
was also provided by the review board (reference number: 11770-[1]). Written informed consent was obtained 
from all subjects within the validation dataset collected in our hospital.
The brain CE-T1WIs and T2WIs archived in the cancer genome atlas glioblastoma multiforme 
(TCGA-GBM)24 and low-grade glioma (TCGA-LGG)25 collections of the cancer imaging archive (TCIA)26 were 
used in this study. Specifically, 157 malignant glioma patients’ preoperative CE-T1WIs and T2WIs (grade III: 55, 
grade IV: 102) with tumor segmentations, which were distributed via a third-party analysis using TCGA-GBM 
and TCGA-LGG collections27–29, were used as the primary dataset. The CE-T1WIs and T2WIs distributed by the 
third-party analysis using these collections have been transformed into the same coordinate system and inter-
polated to 1-mm3 isotropic voxels29. The tumor segmentations were delineated using a computerized framework 
and corrected by a neuroradiologist29. In the segmentations, there were three types of labels: (i) non-enhanced 
tumor and necrosis, (ii) enhanced tumor, and (iii) edema region29. Cho et al. verified that in accordance with 
their results, the enhanced and non-enhanced regions should be taken into account for grading the LGGs and 
HGGs17. Therefore, the tumor segmentations excluding the edema regions were used in this study. TCGA-LGG 
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and TCGA-GBM are multicentered collections. Then, the imaging information and patients’ characteristic have 
been mentioned in the cited articles24,25,27–29.
The validation dataset comprised brain CE-T1WIs and T2WIs (with tumor region data) acquired preopera-
tively from 67 malignant glioma patients in our hospital. The mean number of days between image acquisition 
and surgery for all patients was 13.7 (range: 1–67). None of the patients underwent any treatment prior to the 
image acquisition that could influence the intensity of the MR images. Table 1 lists the patients’ characteristics in 
the validation dataset for this study. There were 22 grade III (anaplastic astrocytoma (AA): 8, anaplastic oligoden-
droglioma (AO): 9, anaplastic oligoastrocytoma (AOA): 5) and 45 glioblastoma (GBM) grade IV patients. The 
isocitrate dehydrogenase (IDH) mutation and O6-methylguanine-DNA methyltransferase (MGMT) methylation 
Figure 1. A conceptual design for predicting glioma grades based on radiomic features.
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statuses for the GBM patients are listed in Table 1. The CE-T1WIs and T2WIs were acquired using 3.0-T MR 
scanners (Signa® HDx and HDxt, GE Healthcare, Chicago, IL, USA). The CE-T1WIs were acquired after bolus 
injection of gadolinium-based contrast agents. The ranges of the repetition time (TR)/echo time (TE) for all 
CE-T1WIs were 380–640 ms/8–12 ms. The matrix size, pixel size, slice thickness, and spacing between the slices 
of the CE-T1WIs were 256 × 256, 0.82 × 0.82 mm2, 5.0 mm, and 6.0 mm, respectively. In the T2WIs, the range 
of TR/TE, matrix size, pixel size, slice thickness, and spacing between slices were 4320–4640 ms/80.77–89.28 ms, 
512 × 512, 0.41 × 0.41 mm2, 3.0 mm, and 3.0 mm, respectively. The bit depth of the MR images was 16 bits per 
pixel (bpp). The CE-T1WIs and T2WIs were transformed into the same coordinate system using ITK-SNAP (ver. 
3.6). A radiation technologist (T.N.) manually delineated the tumors excluding the edema regions on the MR 
images for all patients to extract the radiomic features; this delineation was performed under the supervision of 
a radiation oncologist (W.T.) and a radiologist (S.K.) for quality assurance. A commercial radiation treatment 
planning system (Monaco® ver. 5.11, Elekta, Stockholm, Sweden) was used for the tumor delineations.
The radiomic analysis was performed using a commercial numerical programming language (MATLAB® 
ver. R2017a and R2017b, MathWorks, Natick, MA, USA) and an open-source numerical programming language 
(Python® ver. 3.6). There were accessed on two workstations, one with a single 2.26 GHz quad-core central pro-
cessing unit (CPU) (Intel® Xeon® E5607, Intel Corp., Santa Clara, CA, USA) and the other with double 2.67 GHz 
quad-core CPUs (Intel® Xeon® X5550). Both workstations had 16 GB of RAM.
Radiomic features. The radiomic features were extracted from the glioma regions on the CE-T1WIs and 
T2WIs using open-source MATLAB code developed by Vallières et al.30,31 (https://github.com/mvallieres/radi-
omics and https://github.com/mvallieres/radiomics-develop). Intensity normalization was performed for whole 
brain regions of the MR images in the primary and validation datasets using Z-score transformation32. The voxels 
of the MR images in the validation dataset were converted to 1-mm3 isotropic voxels using cubic interpolation 
before extracting the radiomic features. The interpolation for binary images proposed by Herman et al.33 was 
employed to isotropically resample the voxels of tumor mask images derived from the tumor delineation data in 
the validation dataset. The quantitative image features described in the image biomarker standardization initiative 
(IBSI)34 were used in this radiomic analysis. In this study, 8 shape/size features, 18 intensity features, 20 histogram 
features, 11 gray-level co-occurrence matrix (GLCM) features, 13 gray-level run length matrix (GLRLM) features, 
13 gray-level size zone matrix (GLSZM) features, 16 neighboring gray-level dependence matrix (NGLDM), and 
5 neighborhood gray-tone difference matrix (NGTDM) features within the IBSI, which have been widely used 
in radiomic analyses, were adopted as the radiomic features. The details of the radiomic features are provided in 
Supplement 1. A three-dimensional (3D) Coiflet wavelet transform35 was applied to the MR images in order to 
extract the intensity features, histogram features, and GLCM, GLRLM, GLSZM, NGLDM, and NGTDM features 
known as texture features in frequency decomposed images. The frequency components were HHH, HHL, HLH, 
HLL, LHH, LHL, LLH, and LLL, where “H” and “L” denote high-pass and low-pass filters, respectively. Thus, the 
intensity, histogram, and texture features were extracted from the tumor region on the original MR images and 
eight frequency component-filtered images. Figure 2 shows transverse images of a tumor on the original MR 
image (T2WI) and on eight frequency component-filtered images to which the 3D Coiflet wavelet transform had 
been applied. The number of bins for the histogram features was set to 6 bit. The tumor regions on the original MR 
images and filtered images were quantized to calculate the texture features. The quantization was performed range 
of μ ± 3σ, where μ and σ denote the mean and standard deviation (SD) of the voxel values in the tumor regions, 
respectively36. The quantization levels were set to 4, 5, 6, 7, and 8 bit. Figure 3 shows the heat maps of the radiomic 
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IDH mutation status in GBM 
(n = 45)
Mutated: 2 (4.4%)
Wild type: 19 (42.2%)
Unknown: 24 (53.3%)
MGMT methylation status in 




Table 1. Patients’ characteristics in the validation dataset for this study. GBM: glioblastoma, AA: anaplastic 
astrocytoma, AO: anaplastic oligodendroglioma, AOA: anaplastic oligoastrocytoma, IDH: isocitrate 
dehydrogenase, MGMT: O6-methylguanine-DNA methyltransferase.
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features in the primary and validation datasets. The total number of radiomic features was 5912. The radiomic 
features were normalized by Z-score transformation and clustered using Ward’s method37 in these heat maps.
Feature selection. Among the extracted radiomic features, some features would not correlate with the 
malignant glioma grading. Overfitted models for glioma grading would be constructed owing to these uncorre-
lated radiomic features. Therefore, radiomic features were selected using the WMW test and LASSO-LR38,39 to 
construct robust prediction models of the glioma grades. The two-tail WMW test was performed for all extracted 
radiomic features to obtain significant radiomic features (P < 0.001) for grading gliomas. Then, the significant 
radiomic features were utilize to select features using the LASSO-LR. A scikit-learn (ver. 0.19), open ML library 
for Python40 was used for the LASSO-based feature selection. The LASSO-LR can construct a classification model 
with sparse explanatory variables by solving an L1-norm regularized objective function expressed as follows:
∑ λβ β β β= − − − − +
β =
ˆ y h y hx xargmin [ ln( ( , )) (1 )ln(1 ( , ))] ,
(1)i
n

















= …x x xx ( , , , ), (3)i i i p i1, 2, ,
β β ββ = …( ), , , , (4)p1 2
where β̂ is an optimal coefficient vector, n is the number of patients, y is a label for the glioma grades, and λ is a 
hyper-parameter of the regularization. x, β, and p are explanatory vectors comprising the significant radiomic 
features, coefficient vector, and number of the significant radiomic features, respectively. The optimization prob-
lem was solved using a coordinate descent algorithm41. β̂ would be a sparse vector owing to L1-norm regulariza-
tion. The features with non-zero coefficients of the β̂ were selected in this study. λ, the hyper-parameter 
determining the regularization effect in the optimization problem42, was tuned in this study by using a grid search 
technique. In the grid search, five-fold cross-validation (CV) was performed five times in the training set while 
changing the values of the hyper-parameter, and mean values for the area under receiver operating characteristic 
(ROC) curve (or simply the area under the curve (AUC)) for the five-times five-fold CV were calculated for each 
value of the hyper-parameter. The value of the hyper-parameter that maximized the mean AUC value for the 
five-times five-fold CV was used for the regularization Figure 4 shows the mean AUC values for the five-times 
five-fold CV for each value of the regularization hyper-parameter. The range of the hyper-parameter values was 
10−6–102.
Construction of prediction models for glioma grades using machine learning algorithms. The 
scikit-learn was also used in this procedure. The LR, SVM43, SNN44, RF45, and NB46 were used to construct the 
prediction models for the malignant glioma grades using the selected radiomic features. Some hyper-parameters 
of the LR, SVM, SNN, and RF were tuned by the same methodology as that used for feature selection. The ranges 
for tuning the hyper-parameters by using grid search are provided in Supplement 2. In the SVM, a radial basis 
function kernel was used to construct nonlinear models43. Almost all hyper-parameters of the SNN and RF were 
fixed default values provided by scikit-learn40. In the RF, number of trees was fixed to 1000. There was no param-
eter for tuning in the NB. The LOOCV was conducted to evaluate the performance of prediction models derived 
from the LR, SVM, SNN, RF, and NB in the primary dataset. Independent validation was also performed to inves-
tigate the versatility of the radiomic analysis with a few structural MRI sequences for predicting the malignant 
glioma grades using the primary and validation datasets. Specifically, the prediction models were constructed 
using the primary dataset with the selected radiomic features for all folds in the LOOCV; then, the prediction 
Figure 2. Transverse images of a tumor on original magnetic resonance (MR) image (T2-weighted MR image 
(T2WI)) and on eight frequency component-filtered images to which a three-dimensional (3D) Coiflet wavelet 
transform had been applied.
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models were evaluated using the validation dataset with the selected radiomic features. Accuracies, sensitivities, 
specificities, and AUC values for all prediction models were calculated as evaluation indices. Grade III and IV 
gliomas were defined as negative and positive, respectively, for calculating the evaluation indices.
Results
The range and mode of the number of the significant radiomic features for grading malignant gliomas for the 
LOOCV were 593–717 and 638, respectively. The range and mode of the number of selected radiomic features 
for the LOOCV were 21–39 and 30, respectively. The mean percentage of number of selected radiomic features 
for the LOOCV was 0.53%. The mean ± SD of the value of the hyper-parameter of regularization for the LOOCV 
was 5.02 ± 0.76 (95% confidence interval (CI), 4.90–5.14). Table 2 lists the selected radiomic features for all folds 
in the LOOCV of the primary dataset. The number of selected radiomic features for all LOOCV folds in the 
CE-T1WIs and T2WIs were 5 (intensity: 1, GLRLM: 1, GLSZM: 2, NGLDM: 1), and 1 (intensity: 1), respectively.
Figure 5 shows the ROC curves of the prediction models constructed by the five ML algorithms in the LOOCV 
of the primary dataset. The AUC values of the prediction models constructed by the LR, SVM, SNN, RF, and NB 
were 0.915, 0.932, 0.896, 0.902, and 0.867, respectively. Table 3 lists the accuracies, sensitivities, specificities, and 
AUC values of the prediction models in the LOOCV of the primary dataset. The mean ± SD of these four param-
eters for all prediction models were 0.824 ± 0.027 (95% CI, 0.790–0.858), 0.863 ± 0.033 (95% CI, 0.822–0.903), 
0.753 ± 0.065 (95% CI, 0.672–0.833), and 0.902 ± 0.024 (95% CI, 0.873–0.932), respectively. The prediction mod-
els using the SVM demonstrated the best performance for classifying the malignant glioma grades in the LOOCV 
of the primary dataset, based on the resulting AUC value (0.932).
Figure 3. Heat maps of radiomic features in primary and validation datasets.
Figure 4. Mean area under the curve (AUC) values for five-times five-fold cross-validation (CV) for each value 
of a regularization hyper-parameter. The dashed line depicts a hyper-parameter value, which maximizes the 
mean AUC value for five-times five-fold CV.
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Figure 6 shows the ROC curves for all prediction models in the independent validation constructed by using 
selected radiomic features for all folds in the LOOCV. The AUC values of the prediction models constructed by 
the LR, SVM, SNN, RF, and NB were 0.755, 0.731, 0.707, 0.800, and 0.743, respectively. Table 4 lists the accuracies, 
sensitivities, specificities, and AUC values of the prediction models in the independent validation. The mean ± SD 
of these four parameters for all prediction models were 0.758 ± 0.034 (95% CI, 0.716–0.800), 0.822 ± 0.042 (95% 
CI, 0.771–0.874), 0.627 ± 0.149 (95% CI, 0.443–0.812), and 0.747 ± 0.034 (95% CI, 0.705–0.790), respectively. The 
prediction models using the RF demonstrated the best performance in the independent validation, based on the 
resulting AUC value (0.800).
MRI sequence Wavelet Quantization levels Feature type Feature name
CE-T1 LLL — Intensity Median
CE-T1 LHL 8 bit GLRLM Run-length variance
CE-T1 LLL 5 bit GLSZM Gray-level non-uniformity normalized
CE-T1 HLL 7 bit GLSZM Gray-level variance
CE-T1 HLL 7 bit NGLDM High dependence low gray-level emphasis
T2 LLL — Intensity Root mean square
Table 2. Selected radiomic features for all folds in a leave-one-out cross-validation (LOOCV) of the primary 
dataset. CE-T1: contrast-enhanced T1, L: low-pass filter, H: high-pass filter, GLRLM: gray-level run length 
matrix, GLSZM: gray-level size zone matrix, NGLDM: neighboring gray-level dependence matrix.
Figure 5. Receiver operating characteristic (ROC) curves of the prediction models constructed by the five 
machine learning (ML) algorithms in a leave-one-out cross-validation (LOOCV) of the primary dataset.
Machine learning 
algorithm Accuracy Sensitivity Specificity AUC
LR 0.834 0.833 0.836 0.915
SVM 0.866 0.902 0.800 0.932
SNN 0.796 0.833 0.727 0.896
RF 0.815 0.892 0.673 0.902
NB 0.809 0.853 0.727 0.867
Mean ± SD 0.824 ± 0.027 0.863 ± 0.033 0.753 ± 0.065 0.902 ± 0.024
95% CI 0.790–0.858 0.822–0.903 0.672–0.833 0.873–0.932
Table 3. Accuracies, sensitivities, specificities, and area under the curve (AUC) values of prediction models in 
a leave-one-out cross-validation (LOOCV) of the primary dataset. LR: logistic regression, SVM: support vector 
machine, SNN: standard neural network, RF: random forest, NB: naïve Bayes.
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Discussion
The feasibility of predicting malignant glioma grades based on radiomics by using images acquired with two 
structural MRI sequences was investigated herein. The classification of LGGs and HGGs using MR-based radi-
omic frameworks has been investigated and successfully performed in the past15–23. However, this study is focused 
on only classification of the grade III and IV malignant gliomas because it is also crucial to preoperatively classify 
the grade IV and the others gliomas for appropriate surgical planning and prognosis prediction. The primary 
dataset derived from TCIA collection and the validation dataset derived from our institution collection were used 
to evaluate prediction performances. High-dimensional radiomic features were extracted from both CE-T1WIs 
and T2WIs in various feature types, wavelet sub-bands, and quantization levels to comprehensively obtain effec-
tive features for predicting the malignant glioma grades. The effective features were selected by using combination 
of the WMW test and LASSO-LR. Five ML algorithms were applied to construct various prediction models using 
the selected radiomic features for each fold in the LOOCV of the primary dataset. The primary and validation 
datasets with the selected radiomic features for all folds in the LOOCV of the primary dataset were utilized in the 
independent validation. The prediction performances of various models were compared using four evaluation 
indices.
The AUC values of the prediction models constructed by the LR, SVM, and RF in the LOOCV of the primary 
dataset reached 0.90 and those in the SNN and NB reached 0.80. Moreover, the mean AUC values for all predic-
tion models was 0.902 ± 0.024. In general, classification models with AUC values of 1.00–0.90, and 0.90–0.80 are 
regarded as excellent and good, respectively47,48. Therefore, the proposed framework could accurately predict 
malignant glioma grades despite using images acquired with a few structural MRI sequences in the primary 
dataset. The best prediction performance in the LOOCV of the primary dataset was 0.932 of AUC value using the 
SVM. Therefore, the SVM was an effective classifier for predicting the grade III and IV gliomas in the primary 
dataset.
The radiomic features extracted from the CE-T1WIs were dominantly selected for each fold in the LOOCV. 
In addition, there were five radiomic features extracted from the CE-T1WIs and one radiomic feature extracted 
Figure 6. Receiver operating characteristic (ROC) curves for all prediction models in an independent 
validation constructed by using selected radiomic features for all folds in a leave-one-out cross-validation 
(LOOCV).
Machine learning 
algorithm Accuracy Sensitivity Specificity AUC
LR 0.746 0.756 0.727 0.755
SVM 0.746 0.844 0.545 0.731
SNN 0.716 0.867 0.409 0.707
RF 0.806 0.822 0.773 0.800
NB 0.776 0.822 0.682 0.743
Mean ± SD 0.758 ± 0.034 0.822 ± 0.042 0.627 ± 0.149 0.747 ± 0.034
95% CI 0.716–0.800 0.771–0.874 0.443–0.812 0.705–0.790
Table 4. Accuracies, sensitivities, specificities, and area under the curve (AUC) values of prediction models 
in an independent validation. LR: logistic regression, SVM: support vector machine, SNN: standard neural 
network, RF: random forest, NB: naïve Bayes.
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from the T2WIs, which were selected for all folds in the LOOCV using the primary dataset. The selected radiomic 
features for all LOOCV folds comprised almost all texture features extracted from the CE-T1WIs. Tian et al. 
reported that the texture features extracted from the CE-T1WIs contributed the most to optimal feature subsets 
for predicting the LGGs and HGGs and grade III and IV gliomas in the multiple MRI sequences images21. They 
then suggested that the texture features extracted from the CE-T1WIs might lead to high performance while 
grading the gliomas21. Reza et al. have also reported that in accordance with the results of feature importance 
ranking in the feature selection, the radiomic features extracted from the CE-T1WIs were more important than 
those extracted from other structural MRI sequences images23. The result of feature selection for all LOOCV 
folds in this study was consistent with those reports. Cho et al. and Vamvakas et al. have used 7 and 8 bit of fixed 
quantization levels, respectively for extracting the texture features17,19. Then, the values of the quantization levels 
have not been mentioned in almost all previous studies15,16,18,21,22. Few studies have been reported the appropri-
ate values of the quantization levels for grading the gliomas. In this study, five types of values were used to have 
various combinations of quantization levels in the texture features for achieving high performance. The texture 
features derived from high quantization levels (7 and 8 bit) were dominantly selected for all folds in the LOOCV. 
Therefore, the texture features with the high quantization levels might be effective for predicting the malignant 
glioma grades.
The AUC values of the prediction models were greater than 0.70 but less than 0.80 excluding that of the model 
constructed by the RF in the independent validation. These results suggested that the performances for predicting 
the malignant glioma grades in the independent validation were acceptable but not good excluding that of the RF. 
In addition, the mean AUC values for all prediction models in the independent validation was lower than that in 
the LOOCV of the primary dataset. The prediction performance degradation in the independent validation could 
be attributed to the difference in observers for delineating tumors in the primary and validation datasets. The 
performance for the radiomic analysis varied, depending on the MR scanners, imaging parameters, and tumor 
delineations49,50. We used MR images acquired by various scanners and imaging parameters in the entire dataset. 
Therefore, MR intensity normalization was performed as preprocessing for the entire dataset to reduce the influ-
ences on the performances caused by those variabilities. However, in terms of delineation, the tumor regions in 
the primary dataset were delineated by combination of a computerized framework and manual correction by an 
expert29, while tumor regions in the validation dataset were manually delineated by an observer under the super-
vision of two experts. Consequently, the selected radiomic features for all folds in the LOOCV of the primary 
dataset could not have robustness to delineations of the difference observer. The results of independent validation 
suggested that reproducible radiomic features to the observer delineation variability should be investigated to 
obtain high prediction performance in case using difference datasets.
Previous studies20,21 had already proposed radiomics-based frameworks for classifying malignant glioma 
grades using images acquired via multiple MRI sequences. Table 5 lists the prediction performances for malig-
nant glioma grade identification using a radiomic approach in the proposed framework and in previous studies. 
The best prediction performances of the LOOCV and independent validation using the CE-T1WIs and T2WIs 
in the proposed framework were listed in Table 5. Prediction performances with more than 0.90 of the AUC val-
ues reported by Zacharaki et al. were listed in Table 5 because they investigated various combinations of feature 
selection methods and classifiers for grading the malignant gliomas20. The AUC values of the previous studies 
with the multiple MRI sequences were higher than those of our proposed framework with a few structural MRI 
sequences. The frameworks of previous studies using multiple MRI sequences were indeed effective for classifying 
malignant glioma grades. However, there might be selection bias in the prediction performances of the previous 
studies owing to the relatively small datasets used compared with those of this study and using single scanner 
and unified parameters for acquiring MR images in the datasets. Moreover, an independent validation for inves-
tigating versatility to the different datasets was not performed in previous studies. In this study, the AUC values 
of the best prediction performances in the LOOCV and independent validation using datasets with variety were 
reached 0.90 and 0.80, respectively. Therefore, we can conclude that our proposed framework with a few struc-
tural MRI sequences could sufficiently predict malignant glioma grades despite using datasets comprising MR 
images acquired by various scanners and imaging parameters.
There are limitations to our study. Owing to the difficulty of collecting a large number of available malignant 
glioma cases for a study at our institution, the number of cases in the validation dataset was small. In future, a 
multi-institutional study would be more helpful. Moreover, some cases lacked several MRI sequences images 
in the validation dataset owing to retrospective data collection. Therefore, insufficient multiple MRI sequences 
images were available at our institution for comparison with CE-T1WIs and T2WIs, and the prediction perfor-
mances using the CE-T1WIs and T2WIs in this study were compared instead with those using multiple MRI 
sequence images in the previous studies. In addition, the effect of inter-observer tumor delineation variability on 
the prediction performances of the malignant glioma grades, the reproducible features to the delineation variabil-
ity, and an appropriate tumor delineation procedure for radiomic analysis should be investigated in future. Finally, 
although prediction of the glioma grades using preoperative MR images would be useful for planning surgery, 
the genomic statuses of the gliomas (for example IDH mutation, alpha-thalassemia/mental retardation syndrome 
X-linked (ATRX) mutation, TP53 mutation, and 1p19q codeletion2) should be identified using radiomics-based 
analysis (namely radiogenomics) with a few structural MRI sequences for precision medicine. The genomic sta-
tuses of the gliomas were difficult to analyze in this study because genomic analyses were not always performed 
for all cases. In a future study, the proposed framework should be applied to prediction of the genomic features of 
the gliomas by collecting a large quantity of patients’ preoperative MR images and genomic statuses.
In conclusion, we investigated the feasibility of a framework for predicting malignant glioma grades based on 
radiomics using CE-T1WIs and T2WIs. Our proposed framework could sufficiently and easily predict malig-
nant glioma grades by preparing images acquired by a few structural MRI sequences. The proposed framework 
with a few MRI sequences could mitigate the tedious process of tumor contouring on each MRI sequence image 
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compared with the frameworks with multiple MRI sequences. In addition, the best prediction performances of 
this study indicated that our proposed framework with a few MRI sequences could have versatility to varied data-
sets. Our proposed framework for noninvasively grading malignant gliomas based on the preoperative images 
could be an effective tool for selection of appropriate surgery and educating the patients.
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